The DOI matches its Crossref record.
Angiotensin Type 2 Receptor Mediates Valsartan-Induced Hypotension in Conscious Rats
Open accessAbstract
Abstract —Inhibition of the renin-angiotensin system is associated with vasodilation and reduction in blood pressure. We hypothesized that angiotensin type 1 (AT 1 ) receptor (AT 1 R) blockade is associated with increased production of renal nitric oxide (NO) mediated by release of bradykinin (BK). By use of a microdialysis technique, changes in renal interstitial fluid (RIF) BK, NO end products nitrite and nitrate (NOX), and cGMP were monitored in response to intravenous infusion of the AT 1 R blocker valsartan (10 mg/kg), the angiotensin type 2 (AT 2 ) receptor (AT 2 R) blocker PD123319 (50 μg · kg −1 · min −1 ), and the BK B 2 receptor blocker icatibant (10 μg · kg −1 · min −1 ) in conscious rats (n=10) during low sodium intake. RIF BK, NOX, and cGMP significantly increased during valsartan treatment, whereas AT 2 R blockade caused a significant decrease in these autacoids. During icatibant infusion, RIF NOX and cGMP decreased by 64% and 40%, respectively, whereas BK increased. Combined administration of valsartan and icatibant, of valsartan and PD123319 , or of valsartan, PD123319 , and icatibant prevented the increase in RIF cGMP and NOX in response to valsartan alone. These data demonstrate that AT 1 R blockade with valsartan is associated with release of renal BK, which in turn mediates NO production. The results suggest that increased angiotensin II, in response to sodium restriction and valsartan infusion, stimulates AT 2 R, which mediates a BK and NO cascade.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
International Union of Pharmacology. XXIII. The Angiotensin II Receptors
de Gasparo, M., Catt, K. J., Inagami, T., Wright, J. W., & Unger, T. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01458-3 · Cited by 2,132
Self-citationCarey, R. M., & Siragy, H. M. (2003) · Endocrine Reviews · doi:10.1210/er.2003-0001 · Cited by 603
Self-citationIdentification and characterization of a functional mitochondrial angiotensin system
Abadir, P. M., Foster, D. B., Crow, M., Cooke, C. A., Rucker, J. J., Jain, A., Smith, B. J., Burks, T. N., Cohn, R. D., Fedarko, N. S., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1101507108 · Cited by 279
Self-citationThe renin-angiotensin-aldosterone system, glucose metabolism and diabetes
Giacchetti, G., Sechi, L. A., Rilli, S., & Carey, R. M. (2005) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2005.02.003 · Cited by 267
Self-citationAngiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide
Berry, C., Touyz, R., Dominiczak, A. F., Webb, R. C., & Johns, D. G. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.281.6.h2337 · Cited by 259
Metadata
- Authors
- Siragy, H. M., de Gasparo, M., & Carey, R. M.
- Venue
- Hypertension
- Published
- 2000-05
- Volume
- 35
- Issue
- 5
- Pages
- 1074-1077
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2131873159
- Cited by
- 162
- References
- 0
- FWCI
- 12.46
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Angiotensin Type 2 Receptor Mediates Valsartan-Induced Hypotension in Conscious Rats. https://app.cochat.ai/papers/10.1161/01.hyp.35.5.1074
- The paper
- Siragy, H. M., de Gasparo, M., & Carey, R. M. (2000). Angiotensin Type 2 Receptor Mediates Valsartan-Induced Hypotension in Conscious Rats. Hypertension. https://doi.org/10.1161/01.hyp.35.5.1074
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.